Cns Response Inc (CNSO) 0.0250 $CNSO MYnd Analy
Post# of 273254
Posted On: 09/20/2016 5:14:04 AM
Cns Response Inc (CNSO) 0.0250 $CNSO
MYnd Analytics adds genomics to PEER Report, Building a "Gold-Standard" for evidence-based prescribing
GlobeNewswire - Thu May 26, 8:00AM CDT
MYnd Analytics, Inc. (OTCQB:CNSO) has reached agreements with national laboratories to add genetic testing to its PEER Report. This combination offers physicians and patients a unique opportunity to use objective brain and metabolic measures to guide treatment.
3 Stocks Tackling Concussion Issues in Pro Athletes
ACCESSWIRE - Wed Jan 20, 7:45AM CST
REDONDO BEACH, CA / ACCESSWIRE / January 20, 2016 / The 2015 drama Concussion starring Will Smith follows the story of Dr. Bennet Omalu's battle with the National Football League to acknowledge research on the brain damage suffered by professional football players. After examining the brains of many deceased NFL players, Dr. Omalu coined the term chronic traumatic encephalopathy (CTE) to represent the large accumulation of tau protein on the brain causing a wide range of mental problems.
STEM: 1.40 (+0.01), CEMI: 7.36 (+0.07), CUR: 0.32 (+0.02)
MYnd Analytics to be Featured on Varney & Co.
GlobeNewswire - Thu Nov 12, 2:45PM CST
MYnd Analytics, Inc. (OTCQB:CNSO)
CNS Response Shareholders Vote in New Directors, Approve New Name -- MYnd Analytics
GlobeNewswire - Mon Nov 02, 8:00AM CST
CNS Response, Inc. (OTCQB:CNSO)
CNS Response Presents PEER Findings at Military Research Conference
GlobeNewswire - Wed Aug 19, 9:58AM CDT
CNS Response, Inc. (OTCQB:CNSO)
CNS Response Ranked Top 25 in Intellectual Property
GlobeNewswire - Fri Jun 26, 8:30AM CDT
CNS Response, Inc. (OTCQB:CNSO) CNS Response is ranked as one of 25 leading patent holders in pervasive neurotechnology, according to a recently released report on over 800 organizations by researcher SharpBrains. CNS Response is ranked 21, based on the strength of its intellectual property, in the report titled "Pervasive Neurotechnology: A Groundbreaking Analysis of 10,000+ Patent Filings Transforming Medicine, Health, Entertainment, and Business." Other firms ranked according to the IP Strength Index include the Nielsen Company (#1 overall), Medtronic (#3), Microsoft (#4), Neuronetics (#
, Accenture (#10), General Electric (#11), IBM (#14), and Stanford University (#23). The SharpBrains analysis values the neurotech patent portfolio at $2 billion USD in 2015.
MDT: 85.99 (-0.02), IBM: 154.87 (+1.03)
CNS Response to be Featured on "The Doctors"
GlobeNewswire - Tue Jan 27, 1:39PM CST
CNS Response, Inc. (OTCQB:CNSO)
CNS Response CEO Interviewed on CNBC World's Squawk Box
GlobeNewswire - Tue Jan 20, 6:08AM CST
CNS Response, Inc. (OTCQB:CNSO)
Dave Gentry Features Top 5 Healthcare Stocks for 2015 on This Week's RedChip Money Report on Fox Business and Bloomberg
GlobeNewswire - Tue Dec 16, 2:52PM CST
RedChip Companies, Inc. ("RedChip"
, an international small-cap research, investor relations, and media company, today announced that "The RedChip Money Report: Small Stocks Big Money"
TM) television program will feature its top five healthcare companies for 2015 on Fox Business nationwide on Tuesday, December 16 at 10:00 p.m. Pacific (1 a.m. ET). The show will also air on Bloomberg Europe on Sunday, December 21 at 8:30 a.m. and 3:30 p.m. GMT; on Bloomberg U.K. Sunday, December 21 at 5:00 p.m. and 8:30 p.m. GMT; and on Bloomberg Asia on Sunday, December 21 at 3:30 p.m. HKT.
OPXA: 3.40 (-0.08), ATNM: 1.65 (-0.03), AKER: 3.50 (+0.03), CGIX: 1.75 (+0.02)
CNS Response to Host Webinar to Discuss Key Revenue Drivers for Its Unique Mental Health Technology
GlobeNewswire - Wed Dec 10, 6:00AM CST
CNS Response, Inc. (OTCQB:CNSO)
Avoiding the Wrong Medication is the Best Place to Start: CNS Response Congressional Testimony on Suicide Prevention
GlobeNewswire - Thu Nov 20, 9:12AM CST
CNS Response, Inc. (OTCBB:CNSO)
Congressional Testimony From CNS Response to Feature Key Findings in Suicide Prevention
GlobeNewswire - Fri Nov 07, 8:35AM CST
CNS Response, Inc. (OTCBB:CNSO)
MYnd Analytics adds genomics to PEER Report, Building a "Gold-Standard" for evidence-based prescribing
GlobeNewswire - Thu May 26, 8:00AM CDT
MYnd Analytics, Inc. (OTCQB:CNSO) has reached agreements with national laboratories to add genetic testing to its PEER Report. This combination offers physicians and patients a unique opportunity to use objective brain and metabolic measures to guide treatment.
3 Stocks Tackling Concussion Issues in Pro Athletes
ACCESSWIRE - Wed Jan 20, 7:45AM CST
REDONDO BEACH, CA / ACCESSWIRE / January 20, 2016 / The 2015 drama Concussion starring Will Smith follows the story of Dr. Bennet Omalu's battle with the National Football League to acknowledge research on the brain damage suffered by professional football players. After examining the brains of many deceased NFL players, Dr. Omalu coined the term chronic traumatic encephalopathy (CTE) to represent the large accumulation of tau protein on the brain causing a wide range of mental problems.
STEM: 1.40 (+0.01), CEMI: 7.36 (+0.07), CUR: 0.32 (+0.02)
MYnd Analytics to be Featured on Varney & Co.
GlobeNewswire - Thu Nov 12, 2:45PM CST
MYnd Analytics, Inc. (OTCQB:CNSO)
CNS Response Shareholders Vote in New Directors, Approve New Name -- MYnd Analytics
GlobeNewswire - Mon Nov 02, 8:00AM CST
CNS Response, Inc. (OTCQB:CNSO)
CNS Response Presents PEER Findings at Military Research Conference
GlobeNewswire - Wed Aug 19, 9:58AM CDT
CNS Response, Inc. (OTCQB:CNSO)
CNS Response Ranked Top 25 in Intellectual Property
GlobeNewswire - Fri Jun 26, 8:30AM CDT
CNS Response, Inc. (OTCQB:CNSO) CNS Response is ranked as one of 25 leading patent holders in pervasive neurotechnology, according to a recently released report on over 800 organizations by researcher SharpBrains. CNS Response is ranked 21, based on the strength of its intellectual property, in the report titled "Pervasive Neurotechnology: A Groundbreaking Analysis of 10,000+ Patent Filings Transforming Medicine, Health, Entertainment, and Business." Other firms ranked according to the IP Strength Index include the Nielsen Company (#1 overall), Medtronic (#3), Microsoft (#4), Neuronetics (#
, Accenture (#10), General Electric (#11), IBM (#14), and Stanford University (#23). The SharpBrains analysis values the neurotech patent portfolio at $2 billion USD in 2015. MDT: 85.99 (-0.02), IBM: 154.87 (+1.03)
CNS Response to be Featured on "The Doctors"
GlobeNewswire - Tue Jan 27, 1:39PM CST
CNS Response, Inc. (OTCQB:CNSO)
CNS Response CEO Interviewed on CNBC World's Squawk Box
GlobeNewswire - Tue Jan 20, 6:08AM CST
CNS Response, Inc. (OTCQB:CNSO)
Dave Gentry Features Top 5 Healthcare Stocks for 2015 on This Week's RedChip Money Report on Fox Business and Bloomberg
GlobeNewswire - Tue Dec 16, 2:52PM CST
RedChip Companies, Inc. ("RedChip"
, an international small-cap research, investor relations, and media company, today announced that "The RedChip Money Report: Small Stocks Big Money"TM) television program will feature its top five healthcare companies for 2015 on Fox Business nationwide on Tuesday, December 16 at 10:00 p.m. Pacific (1 a.m. ET). The show will also air on Bloomberg Europe on Sunday, December 21 at 8:30 a.m. and 3:30 p.m. GMT; on Bloomberg U.K. Sunday, December 21 at 5:00 p.m. and 8:30 p.m. GMT; and on Bloomberg Asia on Sunday, December 21 at 3:30 p.m. HKT. OPXA: 3.40 (-0.08), ATNM: 1.65 (-0.03), AKER: 3.50 (+0.03), CGIX: 1.75 (+0.02)
CNS Response to Host Webinar to Discuss Key Revenue Drivers for Its Unique Mental Health Technology
GlobeNewswire - Wed Dec 10, 6:00AM CST
CNS Response, Inc. (OTCQB:CNSO)
Avoiding the Wrong Medication is the Best Place to Start: CNS Response Congressional Testimony on Suicide Prevention
GlobeNewswire - Thu Nov 20, 9:12AM CST
CNS Response, Inc. (OTCBB:CNSO)
Congressional Testimony From CNS Response to Feature Key Findings in Suicide Prevention
GlobeNewswire - Fri Nov 07, 8:35AM CST
CNS Response, Inc. (OTCBB:CNSO)
(0)
(0)Scroll down for more posts ▼